Apr 30, 2020
China National Medical Products Administration Approves DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure
Dec 09, 2019
Doptelet ® (avatrombopag) Demonstrates Cost-effectiveness for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
Mar 07, 2019
Bernstein Liebhard LLP Launches Uloric Lawsuit Investigation, After FDA Concludes Febuxostat Increases Risk for Heart-Related Death and Death from All Causes Compared to Alternative Gout Medication
Sep 09, 2018
Xspray Pharma Announces Positive Clinical Data for Its Lead Product Candidate HyNap-Dasa
May 08, 2018
SCYNEXIS Reports First Quarter 2018 Financial Results and Provides Company Update
Apr 17, 2018
Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at 2018 ECCMID(TM) Conference
Apr 12, 2018
Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018
Mar 26, 2018
Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)
Feb 01, 2018
Global Cephalosporin Market Expected to Reach $4,980 Million by 2023 - Allied Market Research
Oct 04, 2017
Shionogi Presents Positive Clinical Efficacy Trial Results And In Vitro Data On Cefiderocol, At IDWeek 2017
Oct 04, 2017
Allergan To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017 In San Diego
Oct 02, 2017
FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ® (ceftazidime and avibactam)
Sep 11, 2017
Medivir Announces Janssen to Discontinue Development of JNJ-4178 for Hepatitis C
Jul 25, 2017
Medivir AB - Interim Report, January - June 2017
May 31, 2017
Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans